Induction Docetaxel/Cisplatin/5-fluorouracil (TPF) as Selector for Chemo Radiation Therapy (RT) Versus Partial Laryngectomy in Advanced Laryngeal Cancer

NCT01073683 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Larynx Cancer

Interventions

PROCEDURE: laryngoscopy
DRUG: Taxotere (Docetaxel), Cisplatin, 5FU

Sponsor

Rabin Medical Center

Collaborators

[object Object]